Clover Health Investments (CLOV) EBIAT (2019 - 2025)
Clover Health Investments (CLOV) has disclosed EBIAT for 7 consecutive years, with -$49.3 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, EBIAT fell 176.24% year-over-year to -$49.3 million, compared with a TTM value of -$85.5 million through Dec 2025, down 98.91%, and an annual FY2025 reading of -$85.5 million, down 98.91% over the prior year.
- EBIAT was -$49.3 million for Q4 2025 at Clover Health Investments, down from -$24.4 million in the prior quarter.
- Across five years, EBIAT topped out at $7.2 million in Q2 2024 and bottomed at -$317.6 million in Q2 2021.
- Average EBIAT over 5 years is -$70.2 million, with a median of -$48.9 million recorded in 2021.
- The sharpest move saw EBIAT crashed 3621.9% in 2021, then surged 124.88% in 2024.
- Year by year, EBIAT stood at -$187.2 million in 2021, then soared by 42.96% to -$106.8 million in 2022, then soared by 36.35% to -$67.9 million in 2023, then skyrocketed by 73.72% to -$17.9 million in 2024, then plummeted by 176.24% to -$49.3 million in 2025.
- Business Quant data shows EBIAT for CLOV at -$49.3 million in Q4 2025, -$24.4 million in Q3 2025, and -$10.6 million in Q2 2025.